All Publications
Antiviral Research: Recombinant polyclonal antibody GIGA-2339 potently and pan-genotypically neutralizes hepatitis B virus
Cell Reports Methods: High-throughput specificity profiling of antibody libraries using ribosome display and microfluidics
Antiviral Research: New technologies in therapeutic antibody development: The next frontier for treating infectious diseases
The Journal of Infectious Diseases: A Potent Recombinant Polyclonal Antibody Therapeutic for Protection Against New Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern
Journal of Clinical Immunology: Sequencing the B Cell Receptor Repertoires of Antibody-Deficient Individuals With and Without Infection Susceptibility
mAbs: Predicting antibody binders and generating synthetic antibodies using deep learning
BioRxiv: Lack of blocking activity in anti-CTLA-4 antibodies reduces toxicity, but not anti-tumor efficacy
BMC Biology: Single-cell transcriptomics reveals the effect of PD-L1/TGF-β blockade on the tumor microenvironment
Nature Biotechnology: Generation of recombinant hyperimmune globulins from diverse B-cell repertoires
mAbs: Affinity maturation of antibodies by combinatorial codon mutagenesis versus error-prone PCR
For media inquiries, please contact us.
